ACON

Handel nachbörslich: 3.50

Aclarion Inc (ACON)

Überblick Nachrichten Preisverlauf Financials Forum Prognose

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Aclarion Inc Stock (ACON) Company Profile

Aclarion Inc

Healthcare (1107)

833 275 2266

8181 ARISTA PLACE, BROOMFIELD

Nächster Verdiensttermin

Neueste SEC-Einreichungen

ACON's Discussions on Twitter

Compare ACON vs VEEV, BTSG, TEM, HQY, HNGE

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
ACON Aclarion Inc	3.50	8.30M	75,700	-7.23M	-7.37M	-17.21
VEEV Veeva Systems Inc	182.94	30.79B	3.20B	908.91M	1.39B	5.4168
BTSG Brightspring Health Services Inc	59.34	11.63B	13.65B	169.86M	412.12M	1.0758
TEM Tempus Ai Inc	49.62	9.48B	1.36B	-302.91M	-219.93M	-1.7182
HQY Healthequity Inc	88.34	7.58B	1.31B	215.20M	408.32M	2.4627
HNGE Hinge Health Inc	58.48	4.71B	646.34M	-512.40M	202.76M	-6.6871

Aclarion Inc Aktie (ACON) Neueste Nachrichten

Finanzdaten der Aclarion Inc-Aktie (ACON)

Aclarion Inc-Aktie (ACON) Insiderhandel

Insiderhandel	Beziehung	Datum	Transaktion	Kosten	#Aktien	Wert ($)	#Aktien Gesamt
Neal David K	Director	May 11 '26	Buy	3.10	2,500	7,750	2,502
Ness Brent	Chief Executive Officer	May 11 '26	Buy	3.18	6,289	19,999	6,300
Wesemann William	Director	May 06 '26	Buy	3.30	1,562	5,155	1,563
Ness Brent	Chief Executive Officer	Nov 26 '25	Buy	6.20	10	62	11

Aclarion Inc (ACON)

Aclarion Inc Stock (ACON) Company Profile

Compare ACON vs VEEV, BTSG, TEM, HQY, HNGE

Aclarion Inc Aktie (ACON) Neueste Nachrichten

Aclarion's Nociscan tech reveals immune-linked back pain subtypes, expanding precision spine care potential. - Pluang

Aclarion Technology Demonstrates Potential Beyond Surgical Planning in New Immune-Biomarker Study - The Manila Times

Aclarion's Nociscan Technology Linked to Immune Signatures in Back Pain Study, Expanding Clinical Applications - Quiver Quantitative

Aclarion’s Nociscan technology used in back pain study - Investing.com

ACON Maintained by Ascendiant Capital -- Price Target Raised to $7.50 - GuruFocus

SentinelOne To Rally Nearly 40%? Here Are 10 Analyst Forecasts For Friday - Benzinga

Aclarion Inc. Warrants (ACONW) Edge Lower as Tight Trading Range Persists at $0.03Algorithmic Stock Picks - thelegaladvocate.com

Aclarion: Board Will Determine Course of Action It Believes Is in Best Interests of Co, Hldrs >ACON - Moomoo

Aclarion to Review Echo Lake Capital’s Unsolicited Proposal - geneonline.com

Aclarion: Echo Lake Communication Contains Numerous Assertions Regarding Governance and Other Matters That Lack Important Context >ACON - Moomoo

Aclarion: Echo Lake Cap Offered to Acquire the Co for $4/Shr in Cash and Contingent Value Rights >ACON - Moomoo

Aclarion, Inc. Comments on Echo Lake Capital’s Letter and Unsolicited Proposal - The Manila Times

Aclarion, Inc. Responds to Echo Lake Capital's Acquisition Proposal and Reaffirms Commitment to Shareholder Value - Quiver Quantitative

Aclarion says board to review Echo Lake Capital's acquisition proposal - marketscreener.com

Aclarion Says Board To Review Echo Lake Capital's Acquisition Proposal - TradingView

Echo Lake Capital Pressures Aclarion Board With Buyout Proposal and Reverse Merger Push - citybiz

Echo Lake Capital Offers To Acquire Aclarion Inc. - marketscreener.com

Echo Lake Capital proposed to acquire Aclarion, Inc.. - marketscreener.com

ACON News | ACLARION INC (NASDAQ:ACON) - ChartMill

Aclarion Inc. (ACON) Slips 1.56% as Shares Approach Key Support at $3.0Hedge Fund Exposure - thelegaladvocate.com

Aclarion Inc. (ACON) Tests Support Zone After 1.56% DeclineAdaptive Moving Average - thelegaladvocate.com

Aclarion Inc. (ACON) Slips 1.8% Amid Low Volume: Support at $3.05 Holds the KeyNHNL Divergence - thelegaladvocate.com

Aclarion Inc. Warrant (ACONW) Declines Sharply, Testing All-Time Low TerritoryBreadth Thrust - Newser

Aclarion Inc. Q1 2026 Earnings: EPS Surpasses Estimates as Company Prioritizes Cost ControlsStock Idea Network - Newser

Aclarion (ACON) upgraded to buy: Here's why - MSN

ACON Stock Price, Quote & Chart | ACLARION INC (NASDAQ:ACON) - ChartMill

Aclarion Q1 2026 Earnings: EPS Surpasses Estimates by 15.2%, Pre-Revenue Stage ContinuesEnergy Earnings Report - Newser

ACONW SEC FilingsACLARION INC 10-K, 10-Q, 8-K Forms - Stock Titan

Aclarion (ACON) Q1 2026 Earnings: $-1.34 EPS Surges Past $-1.58 EstimatesCommunity Watchlist Picks - Newser

Aclarion (ACON) Upgraded to Buy: Here's Why - Yahoo Finance

Aclarion adds Lanman Spinal Neurosurgery to CLARITY trial By Investing.com - Investing.com Nigeria

Why Is Aclarion, Inc. (ACONW) Stock Down Today? - Meyka

Aclarion announces $2.5M stock repurchase plan - MSN

Aclarion (ACON) Crushes Q1 2026 Estimates — EPS $-1.34 Tops ViewsExpert Entry Points - Newser

Aclarion, Inc. (ACON) reports Q1 loss, misses revenue estimates - MSN

Aclarion sees net loss but strengthens cash position - BizWest

ACON SEC FilingsAclarion Inc 10-K, 10-Q, 8-K Forms - Stock Titan

Aclarion, Inc. (ACON) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance

Aclarion, Inc. 1Q 2026: Revenue $21.1K, EPS $(1.34) — 10-Q Summary - TradingView

Aclarion, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com

Aclarion (NASDAQ: ACON) widens Q1 2026 loss but boosts cash with $10.4M raise - Stock Titan

Insider Move: Aclarion Director Makes Bold New Share Purchase - TipRanks

Aclarion director Scott Breidbart acquires $18,011 in stock - Investing.com

Aclarion director Scott Breidbart acquires $18,011 in stock By Investing.com - Investing.com Nigeria

Director at Aclarion (ACON) buys 5,664 Common Stock shares in public trade - Stock Titan

Aclarion director David Neal buys $7,750 in company stock By Investing.com - Investing.com Nigeria

Finanzdaten der Aclarion Inc-Aktie (ACON)

Umsatz

Nettogewinn

Free Cashflow

ENV

Aclarion Inc-Aktie (ACON) Insiderhandel

Ähnlich wie ACON